TRAM
UTHR icon

Tuscan Ridge Asset Management’s United Therapeutics UTHR Stock Holding History

Tuscan Ridge Asset Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-5,800
Closed -$463K – 562
2019
Q3 		$463K Sell
5,800
-2,000
-26% -$161K 0.03% 523
2019
Q2 		$609K Sell
7,800
-8,700
-53% -$814K 0.05% 468
2019
Q1 		$1.94M Buy
+16,500
New +$1.92M 0.14% 193

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Tuscan Ridge Asset Management's UTHR Position: Q4 2019 in Review

Tuscan Ridge Asset Management sold out of United Therapeutics (UTHR) in Q4 2019, closing a stake of 4,650 shares — an estimated $371K sold.

Tuscan Ridge Asset Management first reported a position in UTHR in Q2 2019 and held it in 2 quarters. The position peaked at $422K in Q2 2019. 320 funds tracked by Wall St. Rank hold UTHR as of Q4 2019.

  • Tuscan Ridge Asset Management reported no remaining United Therapeutics position as of Q4 2019 after selling out during the quarter.
  • Tuscan Ridge Asset Management sold 4,650 United Therapeutics shares in Q4 2019, an estimated $371K.
  • Tuscan Ridge Asset Management first reported a position in United Therapeutics in Q2 2019 and held it in 2 quarters.
  • Tuscan Ridge Asset Management's United Therapeutics position peaked at $422K in Q2 2019.
  • 320 funds tracked by Wall St. Rank held United Therapeutics as of Q4 2019.

Based on Tuscan Ridge Asset Management's 13F filing for Q4 2019, filed 14 Feb 2020.